Magnetic resonance imaging for the detection of bone marrow involvement in malignant lymphoma. 2008

Thomas C Kwee, and Robert M Kwee, and Leo F Verdonck, and Marc B Bierings, and Rutger A J Nievelstein
Department of Radiology, University Medical Centre Utrecht, Utrecht, The Netherlands. thomaskwee@gmail.com

This study systematically reviewed the published data regarding the sensitivity of magnetic resonance imaging (MRI) compared with bone marrow biopsy as reference standard for the detection of bone marrow involvement in patients with malignant lymphoma. A systematic search for relevant studies was performed of the PubMed/MEDLINE and Embase databases. Two reviewers independently assessed the methodological quality of each study and the sensitivity of the included studies was calculated. The 11 included studies had moderate methodological quality. Sensitivity of MRI for the detection of bone marrow involvement ranged from 50% to 100%, with a median of 100%. MRI is probably sufficiently sensitive to rule out bone marrow involvement in patients with malignant lymphoma. However, a well-designed study with a large sample size is needed to confirm current results.

UI MeSH Term Description Entries
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D011785 Quality Assurance, Health Care Activities and programs intended to assure or improve the quality of care in either a defined medical setting or a program. The concept includes the assessment or evaluation of the quality of care; identification of problems or shortcomings in the delivery of care; designing activities to overcome these deficiencies; and follow-up monitoring to ensure effectiveness of corrective steps. Quality Assessment, Health Care,Health Care Quality Assessment,Health Care Quality Assurance,Healthcare Quality Assessment,Healthcare Quality Assurance,Quality Assessment, Healthcare,Quality Assurance, Healthcare,Assessment, Healthcare Quality,Assessments, Healthcare Quality,Assurance, Healthcare Quality,Assurances, Healthcare Quality,Healthcare Quality Assessments,Healthcare Quality Assurances,Quality Assessments, Healthcare,Quality Assurances, Healthcare
D012107 Research Design A plan for collecting and utilizing data so that desired information can be obtained with sufficient precision or so that an hypothesis can be tested properly. Experimental Design,Data Adjustment,Data Reporting,Design, Experimental,Designs, Experimental,Error Sources,Experimental Designs,Matched Groups,Methodology, Research,Problem Formulation,Research Methodology,Research Proposal,Research Strategy,Research Technics,Research Techniques,Scoring Methods,Adjustment, Data,Adjustments, Data,Data Adjustments,Design, Research,Designs, Research,Error Source,Formulation, Problem,Formulations, Problem,Group, Matched,Groups, Matched,Matched Group,Method, Scoring,Methods, Scoring,Problem Formulations,Proposal, Research,Proposals, Research,Reporting, Data,Research Designs,Research Proposals,Research Strategies,Research Technic,Research Technique,Scoring Method,Source, Error,Sources, Error,Strategies, Research,Strategy, Research,Technic, Research,Technics, Research,Technique, Research,Techniques, Research
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001706 Biopsy Removal and pathologic examination of specimens from the living body. Biopsies
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity

Related Publications

Thomas C Kwee, and Robert M Kwee, and Leo F Verdonck, and Marc B Bierings, and Rutger A J Nievelstein
February 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Thomas C Kwee, and Robert M Kwee, and Leo F Verdonck, and Marc B Bierings, and Rutger A J Nievelstein
May 1998, Leukemia & lymphoma,
Thomas C Kwee, and Robert M Kwee, and Leo F Verdonck, and Marc B Bierings, and Rutger A J Nievelstein
January 1999, Pathology oncology research : POR,
Thomas C Kwee, and Robert M Kwee, and Leo F Verdonck, and Marc B Bierings, and Rutger A J Nievelstein
January 2003, Annals of oncology : official journal of the European Society for Medical Oncology,
Thomas C Kwee, and Robert M Kwee, and Leo F Verdonck, and Marc B Bierings, and Rutger A J Nievelstein
May 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Thomas C Kwee, and Robert M Kwee, and Leo F Verdonck, and Marc B Bierings, and Rutger A J Nievelstein
August 1991, Blood,
Thomas C Kwee, and Robert M Kwee, and Leo F Verdonck, and Marc B Bierings, and Rutger A J Nievelstein
November 1992, International journal of oncology,
Thomas C Kwee, and Robert M Kwee, and Leo F Verdonck, and Marc B Bierings, and Rutger A J Nievelstein
July 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Thomas C Kwee, and Robert M Kwee, and Leo F Verdonck, and Marc B Bierings, and Rutger A J Nievelstein
April 1988, British journal of cancer,
Thomas C Kwee, and Robert M Kwee, and Leo F Verdonck, and Marc B Bierings, and Rutger A J Nievelstein
January 1987, Acta radiologica (Stockholm, Sweden : 1987),
Copied contents to your clipboard!